Technical Analysis for AKER - Akers Biosciences Inc

Grade Last Price % Change Price Change
grade F 0.42 -0.94% 0.00
AKER closed down 0.94 percent on Wednesday, August 21, 2019, on 29 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AKER trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.94%
Calm After Storm Range Contraction -0.94%
Narrow Range Bar Range Contraction -0.94%

Older signals for AKER ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Akers Biosciences, Inc. focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. It provides BreathScan to detect the presence of alcohol in an individual's breath; BreathScan PRO that are single-use detectors, a disposable breath alcohol detector; Metron, a simple breath test for weight loss; PIFA heparin/PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; Tri-Cholesterol Test to screen for elevated cholesterol as a risk factor in coronary artery disease; and Vivo, a system for measuring biological markers of oxidative stress non-invasively through a breath test, as well as rapid blood typing cards. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.
Medicine Medical Specialties Antibodies Cholesterol Coronary Artery Disease Glycosaminoglycans Heparin Induced Thrombocytopenia Heparins Thrombocytopenia
Is AKER a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.92
52 Week Low 0.4
Average Volume 183,521
200-Day Moving Average 0.9487
50-Day Moving Average 0.4642
20-Day Moving Average 0.4377
10-Day Moving Average 0.4514
Average True Range 0.0502
ADX 30.13
+DI 26.4806
-DI 14.963
Chandelier Exit (Long, 3 ATRs ) 0.5294
Chandelier Exit (Short, 3 ATRs ) 0.5506
Upper Bollinger Band 0.5077
Lower Bollinger Band 0.3677
Percent B (%b) 0.37
BandWidth 31.985378
MACD Line -0.0074
MACD Signal Line -0.0074
MACD Histogram 0.0
Fundamentals Value
Market Cap 3.74 Million
Num Shares 8.9 Million
EPS -0.42
Price-to-Earnings (P/E) Ratio -1.00
Price-to-Sales 2.34
Price-to-Book 1.43
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.45
Resistance 3 (R3) 0.45 0.44 0.45
Resistance 2 (R2) 0.44 0.43 0.44 0.44
Resistance 1 (R1) 0.43 0.43 0.43 0.43 0.44
Pivot Point 0.42 0.42 0.42 0.42 0.42
Support 1 (S1) 0.41 0.41 0.41 0.41 0.40
Support 2 (S2) 0.40 0.41 0.40 0.40
Support 3 (S3) 0.39 0.40 0.40
Support 4 (S4) 0.39